Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders' Equity

v3.22.1
Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 3 $ 115,008 $ (103,721) $ 11,290
Beginning balance, shares at Dec. 31, 2020 32,272,309      
Issuance of common shares upon vesting of restricted stock units
Issuance of common shares upon vesting of restricted stock units, shares 65,915      
Issuance of common stock for board of directors’ compensation 272 272
Issuance of common stock for board of directors' compensation, shares 173,554      
Share based compensation 919 919
Net loss (4,649) (4,649)
Issuance of common shares upon exercise of warrants, net of financing costs of $366 $ 2 11,591 11,593
Issuance of common shares upon exercise of options, shares 14,267,250      
Ending balance, value at Mar. 31, 2021 $ 5 127,790 (108,370) 19,425
Ending balance, shares at Mar. 31, 2021 46,779,028      
Beginning balance, value at Dec. 31, 2021 $ 5 132,406 (122,754) 9,657
Beginning balance, shares at Dec. 31, 2021 48,320,986      
Issuance of common shares pursuant to at-the-market registered offering, net of issuance costs of $111 $ 1 3,004 3,005
Issuance of common shares upon public offering, shares 5,975,292      
Issuance of common shares upon vesting of restricted stock units
Issuance of common shares upon vesting of restricted stock units, shares 274,446      
Issuance of common stock for board of directors’ compensation 235 235
Issuance of common stock for board of directors' compensation, shares 489,167      
Share based compensation 521 521
Net loss (4,811) (4,811)
Ending balance, value at Mar. 31, 2022 $ 6 $ 136,166 $ (127,565) $ 8,607
Ending balance, shares at Mar. 31, 2022 55,059,891